SynthesisMedicine2016

The Efficacy of Erlotinib Versus Conventional Chemotherapy for Advanced Nonsmall-Cell Lung Cancer: A PRISMA-Compliant Systematic Review With Meta-Regression and Meta-Analysis.

Hu Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.